Page 17 - Ophthalmic Laser Devices Global Company Share Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ophthalmic laser devices global company share analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ophthalmic Laser Devices Global Company Share Analysis Today - Breaking & Trending Today

BAUSCH HEALTH ANNOUNCES VYZULTA® (LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION), 0.024%, IS NOW APPROVED IN BRAZIL


IS NOW APPROVED IN BRAZIL
SOPHIA ANTIPOLIS, France, and LAVAL, Quebec, April 16, 2021 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”), Bausch + Lomb, its leading global eye health business, and Nicox (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, has received regulatory approval from the Brazilian Health Regulatory Agency (ANVISA – Agência Nacional de Vigilância Sanitária).
VYZULTA is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension in the United States and other territories that have the same indication.
1
“The approval of VYZULTA in Brazil marks its tenth regulatory approval. We will continue to focus our efforts on securing additional regulatory approvals for this important treatment option for people suffering from glaucoma to he ....

United States , Hong Kong , Nova Scotia , South Korea , Thomasj Appio , Gavin Spencer , Lainie Keller , Pharma Bio , Mary Ann Chang , Sophia Antipolis , Sophie Baumont , Bausch Health Companies Inc , Lomb International , Bausch Health Investor Contact , Exchange Commission , Brazilian Health Regulatory Agency , Bausch Health Media Contact , Bausch Lomb Incorporated , Eyevance Pharmaceuticals , Bausch Health , Media Contact , Media France Contact , Health Investor Contact , Health Media Contact , Bausch Health Companies , Euronext Paris ,

Research and Markets: 2021 Report on Global Ophthalmic Viscoelastic Devices (Ophthalmic Devices) - Market Analysis and Forecast Model


Research and Markets: 2021 Report on Global Ophthalmic Viscoelastic Devices (Ophthalmic Devices) - Market Analysis and Forecast Model - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
This report discusses in detail the impact of COVID-19 on Ophthalmic Viscoelastic Devices (OVD) market for the year 2020 and beyond. Ophthalmic viscoelastic devices, also known as OVDs, are devices used during intraocular surgery and are primary composed of sodium hyaluronate, chondroitin sulphate, or hydroxypropyl methylcellulose. These devices protect delicate ocular structures and reduce post operational complications such as corneal edema.
OVDs help maintain pressure in the anterior chamber of the eyes and prevent iris prolapse by maintaining compartmentalization of the eyes. The use of these devices significantly reduces patient recovery times. They are often used in cataract surgeries, including extracapsular and phacoemulsification surgeries. ....

United States , United Kingdom , Czech Republic , New Zealand , South Korea , South Africa , United Arab Emirates , Saudi Arabia , Kostenloser Wertpapierhandel , Laura Wood , E St Office Hours Call , Office Hours Call , Alcon Inc , Viscoelastic Devices , Ophthalmic Devices , Global Market Analysis , Forecast Model , Ophthalmic Viscoelastic Devices , Intraocular Lenses , Market Model , Senior Press Manager , Free Call , Hours Call , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , செக் குடியரசு ,

Ophthalmic Loupes Market Size Worth $668.3 Million By 2027: Grand View Research, Inc.


Ophthalmic Loupes Market Size Worth $668.3 Million By 2027: Grand View Research, Inc.
SAN FRANCISCO, Jan. 20, 2021 /PRNewswire/ The global ophthalmic loupes market size is expected to reach USD 668.3 million by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2020 to 2027. The growing prevalence of different eye diseases such glaucoma, cataract, and refractive errors is main factor expected to drive the overall market growth. Additionally, the growing usage of ophthalmic loupes in performing surgeries and for dental procedures due to its ability to provide higher magnification is expected to contribute towards the market growth. ....

United States , South Africa , San Francisco , Saudi Arabia , South Korea , Kostenloser Wertpapierhandel , Asia Pacific , Rudolf Riester Gmb , Sherry James , Vision Inc , View Research , Ocutech Inc , Surgery Centers , View Research Inc , Grand View Research , North America , Loupes Market Size , Trends Analysis Report By Loupe Type , Galilean Type , Prismatic Type , Loupe Design , Ambulatory Surgery Centers , Segment Forecasts , Loupes Type Outlook , Loupes Design Outlook , Loupes End Use Outlook ,